These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 24935586)

  • 41. Human papillomavirus mRNA testing for the detection of anal high-grade squamous intraepithelial lesions in men who have sex with men infected with HIV.
    Sendagorta E; Romero MP; Bernardino JI; Beato MJ; Alvarez-Gallego M; Herranz P
    J Med Virol; 2015 Aug; 87(8):1397-403. PubMed ID: 25940055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
    Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
    J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
    Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
    Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.
    Keegan H; Mc Inerney J; Pilkington L; Grønn P; Silva I; Karlsen F; Bolger N; Logan C; Furuberg L; O'Leary J; Martin C
    J Virol Methods; 2009 Jan; 155(1):61-6. PubMed ID: 18955086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
    Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
    J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. E6/E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure.
    Hovland S; Muller S; Skomedal H; Mints M; Bergström J; Wallin KL; Karlsen F; Johansson B; Andersson S
    Int J Oncol; 2010 Jun; 36(6):1533-9. PubMed ID: 20428778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions.
    Li J; Gao JJ; Li N; Wang YW
    Arch Virol; 2021 Mar; 166(3):853-862. PubMed ID: 33486629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
    Pierry D; Weiss G; Lack B; Chen V; Fusco J
    Arch Pathol Lab Med; 2012 Aug; 136(8):956-60. PubMed ID: 22849745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type-specific prevalence of human papillomavirus by cervical cytology among women in Brasov, Romania.
    Moga MA; Irimie M; Oanta A; Pascu A; Burtea V
    Asian Pac J Cancer Prev; 2014; 15(16):6887-92. PubMed ID: 25169541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection and genotyping of cervical HPV with simultaneous cervical cytology in Turkish women: a hospital-based study.
    Yuce K; Pinar A; Salman MC; Alp A; Sayal B; Dogan S; Hascelik G
    Arch Gynecol Obstet; 2012 Jul; 286(1):203-8. PubMed ID: 22395863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.
    Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
    Int J Gynecol Cancer; 2008; 18(1):121-7. PubMed ID: 17506843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.
    Salimović-Bešić I; Hukić M
    Epidemiol Infect; 2015 Sep; 143(12):2604-12. PubMed ID: 25578155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
    Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
    J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
    Jiang B; Xue M
    Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.